Horwitz, Katherine B, & Mallin, Sanford . Re: Rezulin (troglitazone). Letter to Endocrinologic and Metabolic Drugs Advisory Committee of the FDA. Bethesda, MD: Endocrine Society, 24 March 1999.
Back to resources page
Home | History | Resources | About the author | Contact
